Omote K, Kawamata T, Nakayama Y, Kawamata M, Hazama K, Namiki A
Department of Anesthesiology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Anesth Analg. 2001 Jan;92(1):233-8. doi: 10.1097/00000539-200101000-00045.
Mechanically evoked pain, also known as incident pain, induced by coughing or deep breathing after surgery leads to potentially devastating consequences. It is generally thought that the prostaglandin receptor- (especially, the receptor for prostaglandin E(2), EP receptor) mediated sensitization of sensory nerve fibers is a key contributor to the generation of hyperalgesia. We examined whether a peripherally administered novel selective EP(1) antagonist, ONO-8711, would be a potential analgesic for incision-induced mechanical hyperalgesia. We used a rat model of postoperative pain introduced by Brennan et al. (1). Withdrawal thresholds to punctate stimulation and response frequencies to nonpunctate mechanical stimulation were determined by using von Frey filaments applied adjacent to the wound and directly to the incision site of the hind paw, respectively. Mechanical hyperalgesia to punctate and nonpunctate stimuli was observed 2 and 24 h after the incision. ONO-8711 (2, 10, or 50 microg) or saline was administered subcutaneously into the hind paw on the ipsilateral side to the incision. ONO-8711 significantly (P < 0.01) increased the withdrawal thresholds to punctate mechanical stimulation and significantly (P < 0.01) decreased the response frequencies to nonpunctate mechanical stimulation in a dose- and time-dependent manner 2 and 24 h after the incision. We conclude that EP(1) receptor-mediated sensitization of sensory nerve fibers may contribute to the generation of mechanical hyperalgesia produced by incisional surgery, and that the EP(1) receptor antagonist ONO-8711 may be an option for treatment of postoperative pain, especially incident pain.
The peripheral administration of an antagonist for EP(1) receptor that is a subtype of prostaglandin E receptors can inhibit the mechanical hyperalgesia induced by a surgical incision.
机械诱发的疼痛,也称为偶发性疼痛,术后咳嗽或深呼吸诱发的这种疼痛会导致潜在的严重后果。一般认为,前列腺素受体(尤其是前列腺素E2受体,EP受体)介导的感觉神经纤维敏化是痛觉过敏产生的关键因素。我们研究了外周给予新型选择性EP1拮抗剂ONO-8711是否可能成为切口诱发的机械性痛觉过敏的潜在镇痛药。我们使用了Brennan等人(1)介绍的大鼠术后疼痛模型。分别通过将von Frey细丝应用于伤口附近和直接应用于后爪切口部位,来测定对点状刺激的撤针阈值和对非点状机械刺激的反应频率。在切口后2小时和24小时观察到对点状和非点状刺激的机械性痛觉过敏。将ONO-8711(2、10或50微克)或生理盐水皮下注射到切口同侧的后爪。在切口后2小时和24小时,ONO-8711以剂量和时间依赖性方式显著(P<0.01)提高了对点状机械刺激的撤针阈值,并显著(P<0.01)降低了对非点状机械刺激的反应频率。我们得出结论,EP1受体介导的感觉神经纤维敏化可能有助于切口手术产生的机械性痛觉过敏的产生,并且EP1受体拮抗剂ONO-8711可能是治疗术后疼痛尤其是偶发性疼痛的一种选择。
外周给予作为前列腺素E受体亚型的EP1受体拮抗剂可抑制手术切口诱发的机械性痛觉过敏。